My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

NovoCure Limited - Ordinary Shares (NQ:NVCR)

11.36 -0.03 (-0.26%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about NovoCure Limited - Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 9

...

12 13 Next >

Stocks That Hit 52-Week Lows On Tuesday ↗

June 06, 2023

On Tuesday, 69 stocks hit new 52-week lows.

Via Benzinga

Stocks Mixed As VIX Extends Lows ↗

June 06, 2023

Stocks are struggling for direction midday.

Via Talk Markets

Novocure's Cancer Treating Electric Fields Improves Survival In Lung Cancer Patients, But Stock Tumbles On Remaining Doubts ↗

June 06, 2023

Via Benzinga

The Latest Analyst Ratings for NovoCure ↗

June 06, 2023

Via Benzinga

Why NovoCure Stock Is Crashing Today ↗

June 06, 2023

Analysts weren't wowed by the company's late-stage data.

Via The Motley Fool

NovoCure's Return On Capital Employed Overview ↗

May 18, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

June 06, 2023

Via Benzinga

Why THOR Industries Shares Are Trading Higher By 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

June 06, 2023

Gainers Recruiter.com Group, Inc. (NASDAQ: RCRT) shares jumped 114% to $0.41. Recruiter.com signed a definitive agreement for planned purchase of fintech assets of GoLogiq.

Via Benzinga

Nasdaq Edges Higher; Joann Shares Plummet ↗

June 06, 2023

U.S. stocks traded mixed midway through trading, with Nasdaq Composite turning higher on Tuesday. The Dow traded down 0.08% to 33,534.50 while the NASDAQ rose 0.27% to 13,265.27. The S&P 500, also...

Via Benzinga

4 Analysts Have This to Say About NovoCure ↗

May 16, 2023

Via Benzinga

Should You Buy Novocure Stock Right Now? ↗

May 05, 2023

Most Wall Street analysts think this stock will skyrocket. They could be right.

Via The Motley Fool

Coinbase, Blue Bird, Tingo Group And Other Big Stocks Moving Lower On Tuesday ↗

June 06, 2023

U.S. stocks traded mixed, with the Nasdaq Composite rising around 0.2% on Tuesday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Novocure Crashes Almost 30% As Critics Question Its 'Profound' Impact In Lung Cancer Treatment ↗

June 06, 2023

Novocure said its device, Optune, extended overall survival by more than three months for some lung cancer patients.

Via Investor's Business Daily

Dow Drops 50 Points; J.M. Smucker Earnings Top Views ↗

June 06, 2023

U.S. stocks traded lower this morning, with Dow Jones dropping around 50 points on Monday. The Dow traded down 0.16% to 33,509.87 while the NASDAQ fell 0.19% to 13,203.91. The S&P 500, also fell,...

Via Benzinga

3 No-Brainer Stocks to Buy for Under $100 Right Now ↗

May 27, 2023

These stocks might not remain under $100 for too much longer.

Via The Motley Fool

Benzinga's Top Ratings Upgrades, Downgrades For May 16, 2023 ↗

May 16, 2023

Via Benzinga

NovoCure (NVCR) Q1 2023 Earnings Call Transcript ↗

May 04, 2023

NVCR earnings call for the period ending March 31, 2023.

Via The Motley Fool

Novocure Stock Dips As Q1 Earnings Miss Estimates, Higher Costs Hurt Bottom Line ↗

May 04, 2023

Via Benzinga

NovoCure: Q1 Earnings Insights ↗

May 04, 2023

Via Benzinga

The 3 Most Promising Healthcare Tech Stocks for April 2023 ↗

April 26, 2023

The best healthcare tech stocks provide investors with impressive upside potential, while promising to improve the healthcare sector.

Via InvestorPlace

Benzinga's Top Ratings Upgrades, Downgrades For March 17, 2023 ↗

March 17, 2023

Via Benzinga

What 4 Analyst Ratings Have To Say About NovoCure ↗

March 17, 2023

Via Benzinga

2 Best Defensive Stocks to Buy in March ↗

March 08, 2023

These two defensive stocks should shine in the event of a marketwide correction.

Via The Motley Fool

NovoCure Earnings Perspective: Return On Capital Employed ↗

February 27, 2023

Via Benzinga

2 Stocks That Could Rebound and Rise 30% or More in 2023 ↗

March 10, 2023

They're down, but they aren't yet out.

Via The Motley Fool

Why NovoCure Stock Is Falling Today ↗

February 23, 2023

Investors were looking for a stronger Q4 from the cancer company.

Via The Motley Fool

NovoCure (NVCR) Q4 2022 Earnings Call Transcript ↗

February 23, 2023

NVCR earnings call for the period ending December 31, 2022.

Via The Motley Fool

Why Novocure Stock Was so Healthy Today ↗

February 15, 2023

There was good news from the laboratory on Hump Day.

Via The Motley Fool

Why Novocure Stock Is Sliding Today ↗

January 19, 2023

Investors reacted negatively to the oncology treatment specialist's game of C-suite musical chairs.

Via The Motley Fool

Earnings Scheduled For February 23, 2023 ↗

February 23, 2023

Companies Reporting Before The Bell • ChipMOS TECHNOLOGIES (NASDAQ:IMOS) is likely to report earnings for its fourth quarter.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.